Sweden vs United Kingdom: Access to anti-retroviral drugs, female (%)
Sweden
96.0%
in 2022
United Kingdom
96.0%
in 2023
Sweden rank
14th
United Kingdom rank
14th
Access to anti-retroviral drugs, female (%) over time
- Sweden
- United Kingdom
How they compare
Sweden currently reports 96.0% against 96.0% in United Kingdom, a difference of 0.0%.
Across all 7 years both countries report, Sweden has been ahead every year.
Sweden ranks 14th and United Kingdom ranks 14th of 141 countries.
Sweden has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Sweden | United Kingdom | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 96.0% | 88.0% | 8.0% | Sweden |
| 2020s | 95.7% | 89.0% | 6.7% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Sweden or United Kingdom?
- Sweden, at 96.0% against 96.0% in United Kingdom as of 2022.
- What is the difference in access to anti-retroviral drugs, female between Sweden and United Kingdom?
- 0.0%, with Sweden ahead.
- How many years of comparable data are there for Sweden and United Kingdom?
- 7 years are reported by both, from 2016 to 2022.
- How do Sweden and United Kingdom rank globally for access to anti-retroviral drugs, female?
- Sweden ranks 14th and United Kingdom ranks 14th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.